Company Filing History:
Years Active: 1994-1997
Title: Innovator Gregory A Kopia: Pioneering Bio-Affecting Compounds
Introduction: Gregory A Kopia is a distinguished inventor based in Phoenixville, Pennsylvania. With a strong background in the field of bio-affecting substances, he has made significant contributions that are reflected in his two patents. His work focuses on the development of compounds and methods that enhance therapeutic delivery and bio-analytical techniques.
Latest Patents: Gregory A Kopia's latest patents include innovative methods and compounds. The first patent details "Compounds, compositions and methods for binding bio-affecting substances." These compounds are designed to attach therapeutically active substances to lipid-containing bio-compatible particles, such as cells or viruses. This technology supports site-selective delivery of therapeutic agents for various medical conditions, including post-angioplasty restenosis, rheumatoid arthritis, tumor cell proliferation related to ovarian cancer, and psoriasis.
The second patent, "Bio-analytical separation method," outlines a separation technique used in bio-analytical contexts such as cell screening and blood flow measurement. This method utilizes a carrier that holds a bio-affecting compound to create distinct extractant and carrier phases, significantly improving fluorescence efficiency. This advancement is particularly important for fluorometric determinations in bio-analytical applications.
Career Highlights: Gregory has built his career at Zynaxis, Inc., where he has contributed to groundbreaking research and innovation in the field of bio-affecting compounds. His commitment to advancing health science through innovative solutions highlights his impact on modern therapeutic methodologies.
Collaborations: Throughout his career, Gregory has collaborated with professionals such as Brian D Gray and Sue Ellen Slezak. These partnerships have undoubtedly fostered a dynamic environment for creativity and innovation at Zynaxis, enhancing the potential for significant breakthroughs in health science.
Conclusion: Gregory A Kopia stands out as a prominent inventor in the realm of bio-affecting substances. His two patents reflect a commitment to improving therapeutic delivery methods and bio-analytical techniques. As the landscape of health science continually evolves, Gregory's contributions are likely to inspire further innovations in medical treatments and research methodologies.